var data={"title":"Nontuberculous mycobacterial skin and soft tissue infections in children","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Nontuberculous mycobacterial skin and soft tissue infections in children</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/contributors\" class=\"contributor contributor_credentials\">Andrea T Cruz, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/contributors\" class=\"contributor contributor_credentials\">Mary M Torchia, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 29, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1060356409\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nontuberculous mycobacteria (NTM) are a miscellaneous collection of acid-fast bacteria that are widespread in the environment [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/1\" class=\"abstract_t\">1</a>]. They have been isolated from numerous environmental sources including water, soil, food products, and domestic and wild animals [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"abstract_t\">2</a>]. Health care-associated transmission has occurred with medical equipment [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/3-5\" class=\"abstract_t\">3-5</a>].</p><p>More than 130 species of have been identified, not all of which have been documented to cause disease in humans [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/6-9\" class=\"abstract_t\">6-9</a>]. NTM pathogens are classified as rapidly growing or slowly growing (<a href=\"image.htm?imageKey=ID%2F61936\" class=\"graphic graphic_table graphicRef61936 \">table 1</a>). Rapidly growing species grow within seven days and include <em>Mycobacterium fortuitum, Mycobacterium abscessus,</em> and <em>Mycobacterium chelonae</em>. Slowly growing species require several weeks to grow and include <em>Mycobacterium avium </em>complex (MAC),<em> Mycobacterium marinum, </em>and<em> Mycobacterium kansasii</em>. (See <a href=\"topic.htm?path=microbiology-of-nontuberculous-mycobacteria#H2\" class=\"medical medical_review\">&quot;Microbiology of nontuberculous mycobacteria&quot;, section on 'Classification'</a>.)</p><p>NTM can cause a broad range of infections that vary depending on the particular NTM species and the host. In children, NTM cause four main clinical syndromes: lymphadenopathy, skin and soft tissue infection (SSTI), pulmonary disease (predominantly in children with underlying pulmonary conditions), and disseminated disease (predominantly in children with immune compromise).</p><p>This topic will provide an overview of NTM SSTI infections, focusing on immune competent children. NTM lymphadenitis, pulmonary infections, disseminated infection, and bacteremia in children are discussed separately. (See <a href=\"topic.htm?path=nontuberculous-mycobacterial-lymphadenitis-in-children\" class=\"medical medical_review\">&quot;Nontuberculous mycobacterial lymphadenitis in children&quot;</a> and <a href=\"topic.htm?path=nontuberculous-mycobacterial-pulmonary-infections-in-children\" class=\"medical medical_review\">&quot;Nontuberculous mycobacterial pulmonary infections in children&quot;</a> and <a href=\"topic.htm?path=disseminated-nontuberculous-mycobacterial-ntm-infections-and-ntm-bacteremia-in-children\" class=\"medical medical_review\">&quot;Disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children&quot;</a>.)</p><p>Infections caused by <em>Mycobacterium leprae</em> and <em>Mycobacterium ulcerans</em> (Buruli ulcer) are discussed separately. (See <a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy\" class=\"medical medical_review\">&quot;Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy&quot;</a> and <a href=\"topic.htm?path=treatment-and-prevention-of-leprosy\" class=\"medical medical_review\">&quot;Treatment and prevention of leprosy&quot;</a> and <a href=\"topic.htm?path=buruli-ulcer-mycobacterium-ulcerans-infection\" class=\"medical medical_review\">&quot;Buruli ulcer (Mycobacterium ulcerans infection)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1060356416\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common causes of NTM SSTI include <em>M. fortuitum</em>, <em>M. abscessus</em>, and <em>M. chelonae</em>, which are rapidly growing species; <em>M. marinum</em>; and<em> M. ulcerans</em>, which are slowly growing species<em> </em>[<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/9-14\" class=\"abstract_t\">9-14</a>]<em>.</em> Rapidly growing NTM species are resistant to commonly used disinfectants (eg, chlorine, formaldehyde, glutaraldehyde, organomercurial compounds) and may grow in nonspecific culture media [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/15,16\" class=\"abstract_t\">15,16</a>].</p><p>The microbiology, culture requirements, and methods of speciation for NTM are discussed separately. (See <a href=\"topic.htm?path=microbiology-of-nontuberculous-mycobacteria\" class=\"medical medical_review\">&quot;Microbiology of nontuberculous mycobacteria&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1060356423\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Estimates of the true burden of NTM infections in children are unavailable, in part because NTM infections may be asymptomatic and because NTM infections are not communicable reporting of NTM infections is not required in the United States or many other countries [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"abstract_t\">2</a>]. The overall prevalence of NTM disease appears to be increasing with time (possibly as a result of enhanced detection) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/14,15,17-20\" class=\"abstract_t\">14,15,17-20</a>]. (See <a href=\"topic.htm?path=epidemiology-of-nontuberculous-mycobacterial-infections\" class=\"medical medical_review\">&quot;Epidemiology of nontuberculous mycobacterial infections&quot;</a>.)</p><p>NTM are transmitted through environmental sources. Water (from both natural and treated sources) is a common reservoir [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/21-25\" class=\"abstract_t\">21-25</a>]. Aquatic transmission of NTM is facilitated by the formation of biofilms. Biofilms permit survival under a variety of environmental conditions. Detachment of biofilms allows dissemination of large numbers of organisms [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/26\" class=\"abstract_t\">26</a>]. (See <a href=\"topic.htm?path=pathogenesis-of-nontuberculous-mycobacterial-infections\" class=\"medical medical_review\">&quot;Pathogenesis of nontuberculous mycobacterial infections&quot;</a>.)</p><p>Skin abrasions and penetrating trauma (including injections, piercing, acupuncture, tattooing, surgical procedures) are the usual portal of entry for NTM SSTI [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/11,27-38\" class=\"abstract_t\">11,27-38</a>]. The incubation period is variable [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/9\" class=\"abstract_t\">9</a>]. In outbreaks of cutaneous infection due to rapidly growing mycobacteria (eg, <em>M. abscessus</em>, <em>M. chelonae</em>, <em>M. fortuitum</em>), the incubation period was approximately one month but ranged from 12 to 119 days [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/29,39-41\" class=\"abstract_t\">29,39-41</a>]. In a review of 40 cases of <em>M. marinum</em> infection, the median incubation period was 21 days (range 5 to 270 days) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/42\" class=\"abstract_t\">42</a>].</p><p class=\"headingAnchor\" id=\"H1060356430\"><span class=\"h1\">CLINICAL FEATURES</span></p><p class=\"headingAnchor\" id=\"H1510067549\"><span class=\"h2\">General features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NTM SSTI typically occurs in healthy children with cutaneous exposure to NTM. NTM SSTI also occurs in children with immune deficiency and may be an early sign of disseminated NTM disease (<a href=\"image.htm?imageKey=PEDS%2F86162\" class=\"graphic graphic_picture graphicRef86162 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,43-47\" class=\"abstract_t\">2,43-47</a>]. (See <a href=\"topic.htm?path=disseminated-nontuberculous-mycobacterial-ntm-infections-and-ntm-bacteremia-in-children#H564807774\" class=\"medical medical_review\">&quot;Disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children&quot;, section on 'Clinical features'</a>.)</p><p>NTM SSTI typically follow cutaneous trauma in swimming pools, aquariums, or natural bodies of water [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/47-49\" class=\"abstract_t\">47-49</a>]. Cutaneous infection may occur at the site of surgery, vascular catheters, injections, piercing, or acupuncture [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/11,27-33\" class=\"abstract_t\">11,27-33</a>].</p><p>Cutaneous NTM infections are polymorphous [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/50,51\" class=\"abstract_t\">50,51</a>]. Ulcerations (<a href=\"image.htm?imageKey=ID%2F68569\" class=\"graphic graphic_picture graphicRef68569 \">picture 2</a>), plaques, folliculitis, erythematous papules, and nodules (<a href=\"image.htm?imageKey=ID%2F81640\" class=\"graphic graphic_picture graphicRef81640 \">picture 3</a>) have been described [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/50,52,53\" class=\"abstract_t\">50,52,53</a>]. The variations in clinical presentation may contribute to delays in diagnosis.</p><p>NTM skin and soft tissue disease often starts as a slowly growing indurated area that begins to ulcerate after a few weeks. In contrast to other pyogenic infections, most NTM lesions are painless (<em>Mycobacterium haemophilum </em>is the exception), systemic signs of inflammation are absent, and regional lymphadenopathy is uncommon [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/51\" class=\"abstract_t\">51</a>].</p><p class=\"headingAnchor\" id=\"H1510067648\"><span class=\"h2\">Rapidly growing NTM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cutaneous infections with rapidly growing mycobacteria (eg, <em>M. fortuitum, M. abscessus, M. chelonae) </em>may occur following puncture wounds, surgical procedures, dental procedures, open fractures, or water exposure (eg, wading pools, whirlpool footbaths) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/15,36,39,41,54,55\" class=\"abstract_t\">15,36,39,41,54,55</a>]. In outbreaks of SSTI due to rapidly growing mycobacteria (eg, <em>M. abscessus</em>, <em>M. chelonae</em>, <em>M. fortuitum</em>), the incubation period was approximately one month, but ranged from 12 to 119 days [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/29,39-41\" class=\"abstract_t\">29,39-41</a>].</p><p>Although there is a wide spectrum of manifestations, SSTI caused by a rapidly growing NTM usually manifest as localized cellulitis, draining abscess, or an individual nodule with minimal tenderness [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,43,56\" class=\"abstract_t\">2,43,56</a>]. These infections are clinically indistinguishable from those caused by other bacteria (eg, <em>Pseudomonas aeruginosa</em>, <em>Staphylococcus aureus</em>) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/57\" class=\"abstract_t\">57</a>]. Some case series have noted that<em> M. fortuitum</em> infection usually results in a single cutaneous lesion, while <em>M. chelonae</em> and <em>M. abscessus</em> result in multiple lesions [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/58\" class=\"abstract_t\">58</a>].</p><p class=\"headingAnchor\" id=\"H1231497626\"><span class=\"h2\">M. marinum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>SSTI due to <em>M. marinum</em> usually follows cutaneous trauma in (or exposure of traumatized skin to) aquariums, swimming pools, or natural bodies of water [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/47-49\" class=\"abstract_t\">47-49</a>]. The incubation period is variable; in a review of 40 cases of <em>M. marinum</em> SSTI, the median incubation period was 21 days (range 5 to 270 days) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/42\" class=\"abstract_t\">42</a>].</p><p><em>M. marinum</em> lesions are indolent and typically affect the elbows, knees, and dorsum of feet and hands [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/59,60\" class=\"abstract_t\">59,60</a>]. Involvement of the regional lymph nodes is uncommon.</p><p>There are two predominant presentations of <em>M. marinum</em> SSTI [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/15,59\" class=\"abstract_t\">15,59</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Solitary papules that progress to shallow ulcers with scar formation; the lesions resolve over three to five weeks, with or without drainage.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodules that spread cephalad from the site of inoculation (<a href=\"image.htm?imageKey=ID%2F81640\" class=\"graphic graphic_picture graphicRef81640 \">picture 3</a>); this pattern is less common than solitary papules; it may resemble sporotrichosis and other forms of nodular lymphangitis; it generally resolves over several months. (See <a href=\"topic.htm?path=soft-tissue-infections-following-water-exposure#H7\" class=\"medical medical_review\">&quot;Soft tissue infections following water exposure&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=lymphangitis#H5\" class=\"medical medical_review\">&quot;Lymphangitis&quot;, section on 'Nodular lymphangitis'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1231497680\"><span class=\"h2\">M. ulcerans</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical features of <em>M. ulcerans</em> are discussed separately. (See <a href=\"topic.htm?path=buruli-ulcer-mycobacterium-ulcerans-infection#H5\" class=\"medical medical_review\">&quot;Buruli ulcer (Mycobacterium ulcerans infection)&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H23405905\"><span class=\"h2\">M. leprae</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical features of <em>M. leprae</em> are discussed separately. (See <a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy#H15\" class=\"medical medical_review\">&quot;Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy&quot;, section on 'Clinical manifestations and diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H1231497649\"><span class=\"h2\">Immune-compromised host</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin lesions may be the earliest manifestation of disseminated disease in immune-compromised patients (<a href=\"image.htm?imageKey=PEDS%2F86162\" class=\"graphic graphic_picture graphicRef86162 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,43-47\" class=\"abstract_t\">2,43-47</a>]. Immune-compromised patients may have multiple lesions and more frequent ulceration, abscess formation, or local metastatic disease than immune-competent patients [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/54,61\" class=\"abstract_t\">54,61</a>]. Whereas <em>M. avium</em> complex is the most common pathogen isolated in mycobacterial skin infections in human immunodeficiency virus (HIV)-infected children, a variety of species can cause disease in HIV-seronegative immunocompromised children [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/46\" class=\"abstract_t\">46</a>]. (See <a href=\"topic.htm?path=disseminated-nontuberculous-mycobacterial-ntm-infections-and-ntm-bacteremia-in-children#H564807774\" class=\"medical medical_review\">&quot;Disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children&quot;, section on 'Clinical features'</a>.)</p><p class=\"headingAnchor\" id=\"H1231497657\"><span class=\"h2\">Complications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Penetration of NTM into deeper tissues can inoculate muscle planes or bone, resulting in chronic pyomyositis, tenosynovitis, and chronic osteomyelitis [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/51\" class=\"abstract_t\">51</a>]. This occurs in approximately one-third of cases of <em>M. marinum</em> [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/60\" class=\"abstract_t\">60</a>].</p><p>Digital tenosynovitis caused by <em>M. marinum</em> is known as &quot;fish tank finger&quot; [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/62\" class=\"abstract_t\">62</a>]. The signs and symptoms are similar to those of tenosynovitis at other sites: pain and swelling over the tendon, a catching or snapping sensation with movement of the digit, and pain with passive extension of the finger. (See <a href=\"topic.htm?path=infectious-tenosynovitis#H7\" class=\"medical medical_review\">&quot;Infectious tenosynovitis&quot;, section on 'Clinical manifestations'</a>.)</p><p>Most cases of NTM osteomyelitis follow direct inoculation of the organism (eg, an open fracture); however, cases have occurred after blunt (nonpenetrating) trauma [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/63\" class=\"abstract_t\">63</a>]. The epidemiology, clinical features, and diagnosis of NTM osteomyelitis and treatment of NTM osteomyelitis in adults are discussed separately. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-osteomyelitis-due-to-nontuberculous-mycobacteria\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of osteomyelitis due to nontuberculous mycobacteria&quot;</a> and <a href=\"topic.htm?path=treatment-of-osteomyelitis-due-to-nontuberculous-mycobacteria-in-adults\" class=\"medical medical_review\">&quot;Treatment of osteomyelitis due to nontuberculous mycobacteria in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1060356437\"><span class=\"h1\">HISTOPATHOLOGIC FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histopathologic features of NTM SSTI include dermal granulomas (occasionally with suppuration), stellate abscesses, sinus tracts, and acute and chronic inflammation [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/10,27,64,65\" class=\"abstract_t\">10,27,64,65</a>]. However, none of these features is pathognomonic. NTM granulomas often demonstrate neutrophilic infiltration [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/66\" class=\"abstract_t\">66</a>]; eosinophilic infiltration is uncommon. Acid-fast bacilli are seen in a minority of cases (only 3 of 18 specimens in one series) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/50\" class=\"abstract_t\">50</a>].</p><p>The predominant histopathologic findings may vary depending upon the host's immune status. In a review of biopsy specimens from 27 patients with NTM SSTI, granulomas were more common in specimens from immune-competent patients (18 specimens), whereas deep infiltrates into the subcutaneous tissue, abscess formation, and a foamy appearance of macrophages were more common in specimens from immune-compromised hosts (10 specimens from 9 patients) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/10\" class=\"abstract_t\">10</a>].</p><p class=\"headingAnchor\" id=\"H1060356444\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of NTM SSTI requires isolation of a clinically significant NTM species in culture of biopsy, drainage, or aspirate of fluid from skin nodule, wound, or abscess in a child with compatible clinical findings.</p><p class=\"headingAnchor\" id=\"H1231497480\"><span class=\"h2\">Clinical suspicion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical features that should prompt consideration of NTM in children with SSTI include [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/65\" class=\"abstract_t\">65</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of water exposure (eg, swimming pool, aquariums, natural bodies of water, etc)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of penetrating injury, surgical procedure, or injection</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Negative routine bacterial cultures (if performed)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lack of response to <span class=\"nowrap\">antistaphylococcal/antistreptococcal</span> antibiotics (if administered)</p><p/><p>A positive (&ge;5 mm induration) <a href=\"topic.htm?path=tuberculin-skin-test-drug-information\" class=\"drug drug_general\">tuberculin skin test</a> (TST) can support the diagnosis of NTM infection in children without risk factors for <em>Mycobacterium tuberculosis</em> [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/48,53\" class=\"abstract_t\">48,53</a>]. However, a positive TST cannot distinguish between NTM and <em>M. tuberculosis</em>. Nor does a negative (&lt;5 mm induration) TST exclude mycobacterial disease. Interferon gamma release assays, which are typically negative in NTM disease, can be falsely positive in children infected with <em>M. marinum</em>. (See <a href=\"#H1060356451\" class=\"local\">'Differential diagnosis'</a> below and <a href=\"topic.htm?path=tuberculosis-disease-in-children#H11\" class=\"medical medical_review\">&quot;Tuberculosis disease in children&quot;, section on 'Tuberculin skin test'</a>.)</p><p class=\"headingAnchor\" id=\"H1231497487\"><span class=\"h2\">Microbiologic testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Definitive diagnosis of NTM SSTI is made by isolation of NTM in culture of biopsy, drainage, or aspirate of fluid from a skin nodule, wound, or abscess [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"abstract_t\">2</a>]. Culture is essential to differentiate NTM from <em>M. tuberculosis</em>, determine which species of NTM is causing infection, and perform susceptibility testing. However, positive cultures may represent a true pathogen or a contaminant; given the ubiquity of NTM species in tap water, pseudo-outbreaks from contaminated water supplies have been reported [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/67\" class=\"abstract_t\">67</a>].</p><p>It is helpful to discuss specimen collection, transport, and culture processing with the microbiology laboratory before sending tissue or fluid to the laboratory if NTM infection is suspected. Some species of NTM (eg, <em>M. haemophilum</em>) have fastidious growth requirements. Microbiologic techniques to maximize the yield of NTM cultures are discussed separately. Given the fastidious growth requirements of some NTM species, multiplex mycobacterial polymerase chain reaction (PCR) can aid in the diagnosis for culture-negative cases [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/68\" class=\"abstract_t\">68</a>]. (See <a href=\"topic.htm?path=microbiology-of-nontuberculous-mycobacteria\" class=\"medical medical_review\">&quot;Microbiology of nontuberculous mycobacteria&quot;</a>.)</p><p>Positive acid-fast staining supports the diagnosis of mycobacterial disease and increases the likelihood of that the isolate is clinically significant, but does not distinguish between NTM and <em>M. tuberculosis</em> [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/11\" class=\"abstract_t\">11</a>]. The finding of acid-fast bacilli (AFB) in routine bacterial culture also supports the diagnosis of NTM (and is suggestive of a rapidly growing species, such as <em>M. fortuitum</em>, <em>M. abscessus</em>, and <em>M. chelonae</em>)<em> </em>[<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/65\" class=\"abstract_t\">65</a>]<em>.</em></p><p class=\"headingAnchor\" id=\"H1510068134\"><span class=\"h3\">Species identification</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Appropriate antimycobacterial treatment of NTM SSTI requires NTM speciation because different species require different treatments. (See <a href=\"#H1261211787\" class=\"local\">'Specific therapy'</a> below.)</p><p>Rapid methods for identification of NTM species from culture include high-pressure liquid chromatography (HPLC) and PCR [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"abstract_t\">2</a>]. HPLC examines the mycolic acid fingerprint patterns that differ among most species or complexes of mycobacteria and can be used to speciate NTM, including rapidly growing mycobacteria [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/69\" class=\"abstract_t\">69</a>]. HPLC cannot reliably differentiate between <em>M. abscessus</em> and <em>M. chelonae</em>. The role of PCR in the diagnosis of cutaneous NTM disease is unclear. PCR can differentiate between <em>M. abscessus</em> and <em>M. chelonae</em> and has been used to make the diagnosis of NTM SSTI in a few cases [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/70\" class=\"abstract_t\">70</a>]. However, the variety of species causing cutaneous NTM disease and the need for drug susceptibility testing limits the utility of PCR.</p><p>The identification of <em>M. abscessus</em>, <em>M. chelonae</em>, and <em>M. fortuitum</em> may be facilitated by susceptibility testing for <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">amikacin</a>, <a href=\"topic.htm?path=cefoxitin-pediatric-drug-information\" class=\"drug drug_pediatric\">cefoxitin</a>, <a href=\"topic.htm?path=clarithromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">clarithromycin</a>, <a href=\"topic.htm?path=ciprofloxacin-pediatric-drug-information\" class=\"drug drug_pediatric\">ciprofloxacin</a>, <a href=\"topic.htm?path=doxycycline-pediatric-drug-information\" class=\"drug drug_pediatric\">doxycycline</a>, <a href=\"topic.htm?path=linezolid-pediatric-drug-information\" class=\"drug drug_pediatric\">linezolid</a>, sulfamethoxazole, and <a href=\"topic.htm?path=tobramycin-pediatric-drug-information\" class=\"drug drug_pediatric\">tobramycin</a> [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"#H1261211787\" class=\"local\">'Specific therapy'</a> below.)</p><p class=\"headingAnchor\" id=\"H1762312486\"><span class=\"h2\">Clinical significance</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When NTM is isolated from a child with SSTI, the clinical significance of the isolate must be determined. The pathogenicity of the various NTM species varies substantially. The possibility that NTM was isolated as a result of contamination also must be considered because NTM is ubiquitous in the environment [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"abstract_t\">2</a>]. Factors that increase the likelihood that the isolate is clinically significant include recovery from multiple specimens and recovery in large quantities (ie, sufficient to result in AFB positive smears).</p><p>Consultation with a specialist in infectious diseases may be helpful in determining the clinical significance of the isolate.</p><p class=\"headingAnchor\" id=\"H1060356451\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The indolent, chronic, and generally nontender lesions of NTM cutaneous disease can mimic those of a number of other cutaneous disorders. Histopathology <span class=\"nowrap\">and/or</span> microbiology generally are necessary to differentiate between cutaneous NTM and other conditions in the differential diagnosis including [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/54\" class=\"abstract_t\">54</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sporotrichosis (<a href=\"image.htm?imageKey=ID%2F50115%7EID%2F74515\" class=\"graphic graphic_picture graphicRef50115 graphicRef74515 \">picture 4A-B</a>) (see <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-sporotrichosis#H3\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of sporotrichosis&quot;, section on 'Lymphocutaneous sporotrichosis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nocardiosis (see <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-nocardiosis#H6\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of nocardiosis&quot;, section on 'Cutaneous'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous leishmaniasis (<a href=\"image.htm?imageKey=ID%2F64620\" class=\"graphic graphic_picture graphicRef64620 \">picture 5</a>) (see <a href=\"topic.htm?path=cutaneous-leishmaniasis-clinical-manifestations-and-diagnosis#H83446480\" class=\"medical medical_review\">&quot;Cutaneous leishmaniasis: Clinical manifestations and diagnosis&quot;, section on 'Localized cutaneous leishmaniasis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>M. tuberculosis</em> (<a href=\"image.htm?imageKey=DERM%2F65877\" class=\"graphic graphic_picture graphicRef65877 \">picture 6</a>) (see <a href=\"topic.htm?path=cutaneous-manifestations-of-tuberculosis\" class=\"medical medical_review\">&quot;Cutaneous manifestations of tuberculosis&quot;</a>)</p><p/><p>In immunocompromised hosts, disseminated fungal disease also must be considered:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aspergillosis (see <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-invasive-aspergillosis#H625354468\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of invasive aspergillosis&quot;, section on 'Cutaneous aspergillosis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cryptococcal disease (<a href=\"image.htm?imageKey=DERM%2F69214\" class=\"graphic graphic_picture graphicRef69214 \">picture 7</a>) (see <a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system#H26\" class=\"medical medical_review\">&quot;Cryptococcus neoformans infection outside the central nervous system&quot;, section on 'Nonmeningeal, nonpulmonary cryptococcosis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Histoplasmosis (see <a href=\"topic.htm?path=pathogenesis-and-clinical-manifestations-of-disseminated-histoplasmosis#H11\" class=\"medical medical_review\">&quot;Pathogenesis and clinical manifestations of disseminated histoplasmosis&quot;, section on 'Skin involvement'</a>)</p><p/><p class=\"headingAnchor\" id=\"H1060356458\"><span class=\"h1\">MANAGEMENT</span></p><p class=\"headingAnchor\" id=\"H1510068244\"><span class=\"h2\">Overview</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Treatment of NTM SSTI in children often requires a combination of surgical and medical therapy [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/9\" class=\"abstract_t\">9</a>].</p><p>Consultation with a specialist in infectious diseases may be warranted, particularly when rapidly growing NTM (eg, <em>M. fortuitum, M. abscessus, M. chelonae) </em>are isolated. No randomized controlled trials or comparative observational studies have evaluated the efficacy of treatments for NTM SSTI. The treatment recommendations below are based upon case series, in vitro susceptibility testing, and clinical experience [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/71-77\" class=\"abstract_t\">71-77</a>]. Our recommendations are generally consistent with the 2007 American Thoracic Society and the Infectious Diseases Society of America guidelines on the management of NTM diseases and the American Academy of Pediatrics Committee on Infectious Diseases [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,9\" class=\"abstract_t\">2,9</a>].</p><p class=\"headingAnchor\" id=\"H506956714\"><span class=\"h2\">Surgical therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Drainage of abscesses and removal of indwelling foreign bodies, such as intravenous catheters, are essential components of treatment [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,47,78\" class=\"abstract_t\">2,47,78</a>]. In addition, surgical debridement is optimal for serious localized disease (eg, those with tenosynovitis, ulceration, deep soft tissue infections, device-associated SSTI, and SSTI associated with osteomyelitis).</p><p class=\"headingAnchor\" id=\"H1231497809\"><span class=\"h2\">Antimycobacterial therapy</span></p><p class=\"headingAnchor\" id=\"H1261211780\"><span class=\"h3\">Empiric therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest that children with NTM SSTI be treated with antimicrobial therapy rather than observation. In observational studies, spontaneous resolution took as long as 12 months [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/27,79,80\" class=\"abstract_t\">27,79,80</a>]. Antibiotic therapy may hasten resolution [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/79\" class=\"abstract_t\">79</a>].</p><p>Pending NTM speciation, we suggest that children with localized, nonulcerated NTM SSTI be treated based upon the likely species causing the disease, with a macrolide (<a href=\"topic.htm?path=azithromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">azithromycin</a> or <a href=\"topic.htm?path=clarithromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">clarithromycin</a>) <strong>plus</strong> one of the following (<a href=\"image.htm?imageKey=PEDS%2F86161\" class=\"graphic graphic_table graphicRef86161 \">table 2</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fluoroquinolone (eg, <a href=\"topic.htm?path=ciprofloxacin-pediatric-drug-information\" class=\"drug drug_pediatric\">ciprofloxacin</a>), or</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=doxycycline-pediatric-drug-information\" class=\"drug drug_pediatric\">Doxycycline</a> (for children &ge;8 years old), or</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-pediatric-drug-information\" class=\"drug drug_pediatric\">Trimethoprim-sulfamethoxazole</a> (TMP-SMX)</p><p/><p>However, the initial empiric regimen may vary depending upon host factors, suspected species of NTM, and the severity of cutaneous disease. Inclusion of parenterally administered antimicrobial agent(s) in the empiric regimen may be warranted if the patient is immune-compromised or if <em>M. <span class=\"nowrap\">abscessus/M</span>. chelonae</em> is suspected (on the basis of high-pressure liquid chromatography testing, which cannot differentiate between the two species). Some experts recommend initial parenteral therapy for serious disease (eg, ulceration, deep soft tissue infection, device-associated SSTI, and SSTI associated with osteomyelitis) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/9\" class=\"abstract_t\">9</a>]. The suggested initial therapy for serious NTM cutaneous disease varies according to the suspected species [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/9\" class=\"abstract_t\">9</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>M. fortuitum</em> &ndash; <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">Amikacin</a> plus <a href=\"topic.htm?path=meropenem-pediatric-drug-information\" class=\"drug drug_pediatric\">meropenem</a></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>M. abscessus</em> &ndash; <a href=\"topic.htm?path=clarithromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">Clarithromycin</a> plus <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">amikacin</a> plus either <a href=\"topic.htm?path=cefoxitin-pediatric-drug-information\" class=\"drug drug_pediatric\">cefoxitin</a> or <a href=\"topic.htm?path=meropenem-pediatric-drug-information\" class=\"drug drug_pediatric\">meropenem</a></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>M. chelonae</em> &ndash; <a href=\"topic.htm?path=clarithromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">Clarithromycin</a> plus <a href=\"topic.htm?path=tobramycin-pediatric-drug-information\" class=\"drug drug_pediatric\">tobramycin</a> plus either <a href=\"topic.htm?path=meropenem-pediatric-drug-information\" class=\"drug drug_pediatric\">meropenem</a> or <a href=\"topic.htm?path=linezolid-pediatric-drug-information\" class=\"drug drug_pediatric\">linezolid</a></p><p/><p>Isolates of rapidly growing mycobacteria (<em>M. abscessus</em>, <em>M. chelonae</em>, <em>M. fortuitum</em>) should be tested in vitro against antimicrobials including <a href=\"topic.htm?path=clarithromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">clarithromycin</a>, <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">amikacin</a>, <a href=\"topic.htm?path=imipenem-and-cilastatin-pediatric-drug-information\" class=\"drug drug_pediatric\">imipenem</a>, TMP-SMX, <a href=\"topic.htm?path=cefoxitin-pediatric-drug-information\" class=\"drug drug_pediatric\">cefoxitin</a>, <a href=\"topic.htm?path=linezolid-pediatric-drug-information\" class=\"drug drug_pediatric\">linezolid</a>, <a href=\"topic.htm?path=doxycycline-pediatric-drug-information\" class=\"drug drug_pediatric\">doxycycline</a>, and <a href=\"topic.htm?path=ciprofloxacin-pediatric-drug-information\" class=\"drug drug_pediatric\">ciprofloxacin</a>, to which they are often susceptible and for which therapeutic response has been described [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,9\" class=\"abstract_t\">2,9</a>]. Based on in vitro susceptibility testing, a two-drug regimen that includes a macrolide will provide coverage for the most common causes of NTM SSTI in children (<em>M. fortuitum</em>, <em>M. abscessus</em>, <em>M. chelonae</em>, and<em> M. marinum</em>) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,71-73,81,82\" class=\"abstract_t\">2,71-73,81,82</a>].</p><p class=\"headingAnchor\" id=\"H1261211787\"><span class=\"h3\">Specific therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In children with NTM SSTI in whom a particular species has been isolated, we suggest combination therapy with <strong>two</strong> drugs to which the isolate is susceptible. However, in vitro susceptibility testing does not always correlate with clinical response, and the antimicrobial regimen may need to be changed if the child fails to improve after four to six weeks.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>M. fortuitum</em></strong> typically is susceptible to macrolides, <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">amikacin</a>, carbapenems, fluoroquinolones, and TMP-SMX (<a href=\"image.htm?imageKey=PEDS%2F86161\" class=\"graphic graphic_table graphicRef86161 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,71-73,81-84\" class=\"abstract_t\">2,71-73,81-84</a>]. In an in vitro study, <em>M. fortuitum</em> isolates were more susceptible to fluoroquinolones than to other classes of antibiotics [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/84\" class=\"abstract_t\">84</a>]. Single-agent therapy with a macrolide is not recommended because <em>M. fortuitum</em> has inducible macrolide resistance [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/85\" class=\"abstract_t\">85</a>]. (See <a href=\"topic.htm?path=rapidly-growing-mycobacterial-infections-mycobacteria-abscessus-chelonae-and-fortuitum#H18\" class=\"medical medical_review\">&quot;Rapidly growing mycobacterial infections: Mycobacteria abscessus, chelonae, and fortuitum&quot;, section on 'Susceptibility patterns'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>M. abscessus</em></strong> typically is susceptible to macrolides, <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">amikacin</a>, <a href=\"topic.htm?path=cefoxitin-pediatric-drug-information\" class=\"drug drug_pediatric\">cefoxitin</a>, or a carbapenem (eg, <a href=\"topic.htm?path=meropenem-pediatric-drug-information\" class=\"drug drug_pediatric\">meropenem</a>) (<a href=\"image.htm?imageKey=PEDS%2F86161\" class=\"graphic graphic_table graphicRef86161 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/72,73,81-83\" class=\"abstract_t\">72,73,81-83</a>]. Single-agent therapy with a macrolide is not recommended because <em>M. abscessus</em> has inducible macrolide resistance [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/85\" class=\"abstract_t\">85</a>]. (See <a href=\"topic.htm?path=rapidly-growing-mycobacterial-infections-mycobacteria-abscessus-chelonae-and-fortuitum#H18\" class=\"medical medical_review\">&quot;Rapidly growing mycobacterial infections: Mycobacteria abscessus, chelonae, and fortuitum&quot;, section on 'Susceptibility patterns'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>M. chelonae</em></strong> typically is susceptible to macrolides, <a href=\"topic.htm?path=tobramycin-pediatric-drug-information\" class=\"drug drug_pediatric\">tobramycin</a>, and carbapenems (<a href=\"image.htm?imageKey=PEDS%2F86161\" class=\"graphic graphic_table graphicRef86161 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/71-73,81-83\" class=\"abstract_t\">71-73,81-83</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Susceptibility testing generally is not performed for <strong><em>M. marinum</em></strong> isolates unless the patient fails to improve after several months of treatment [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"abstract_t\">2</a>]. <em>M. marinum</em> typically is susceptible to rifamycins (<a href=\"topic.htm?path=rifampin-rifampicin-pediatric-drug-information\" class=\"drug drug_pediatric\">rifampin</a> and <a href=\"topic.htm?path=rifabutin-pediatric-drug-information\" class=\"drug drug_pediatric\">rifabutin</a>), <a href=\"topic.htm?path=ethambutol-pediatric-drug-information\" class=\"drug drug_pediatric\">ethambutol</a>, macrolides, and TMP-SMX (<a href=\"image.htm?imageKey=PEDS%2F86161\" class=\"graphic graphic_table graphicRef86161 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2,9\" class=\"abstract_t\">2,9</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment for <strong><em>M. ulcerans</em></strong> is discussed separately. (See <a href=\"topic.htm?path=buruli-ulcer-mycobacterium-ulcerans-infection#H8\" class=\"medical medical_review\">&quot;Buruli ulcer (Mycobacterium ulcerans infection)&quot;, section on 'Treatment'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of <strong><em>M. leprae</em></strong> is discussed separately. (See <a href=\"topic.htm?path=treatment-and-prevention-of-leprosy#H310298018\" class=\"medical medical_review\">&quot;Treatment and prevention of leprosy&quot;, section on 'Treatment'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2473623173\"><span class=\"h3\">Adverse effects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The antimycobacterial agents that are used to treat NTM SSTI often are difficult to tolerate and some have important toxicities. Important adverse effects include (but are not limited to) ototoxicity and nephrotoxicity with <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">amikacin</a> and <a href=\"topic.htm?path=streptomycin-pediatric-drug-information\" class=\"drug drug_pediatric\">streptomycin</a>, optic neuropathy with <a href=\"topic.htm?path=ethambutol-pediatric-drug-information\" class=\"drug drug_pediatric\">ethambutol</a>, and hepatotoxicity with <a href=\"topic.htm?path=isoniazid-pediatric-drug-information\" class=\"drug drug_pediatric\">isoniazid</a>. The adverse effects of the agents used to treat NTM infections are discussed in greater detail separately. (See <a href=\"topic.htm?path=pathogenesis-and-prevention-of-aminoglycoside-nephrotoxicity-and-ototoxicity\" class=\"medical medical_review\">&quot;Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity&quot;</a> and <a href=\"topic.htm?path=manifestations-of-and-risk-factors-for-aminoglycoside-nephrotoxicity\" class=\"medical medical_review\">&quot;Manifestations of and risk factors for aminoglycoside nephrotoxicity&quot;</a> and <a href=\"topic.htm?path=ethambutol-an-overview\" class=\"medical medical_review\">&quot;Ethambutol: An overview&quot;</a> and <a href=\"topic.htm?path=azithromycin-clarithromycin-and-telithromycin\" class=\"medical medical_review\">&quot;Azithromycin, clarithromycin, and telithromycin&quot;</a> and <a href=\"topic.htm?path=rifamycins-rifampin-rifabutin-rifapentine\" class=\"medical medical_review\">&quot;Rifamycins (rifampin, rifabutin, rifapentine)&quot;</a> and <a href=\"topic.htm?path=isoniazid-an-overview\" class=\"medical medical_review\">&quot;Isoniazid: An overview&quot;</a> and <a href=\"topic.htm?path=isoniazid-hepatotoxicity\" class=\"medical medical_review\">&quot;Isoniazid hepatotoxicity&quot;</a> and <a href=\"topic.htm?path=aminoglycosides#H27\" class=\"medical medical_review\">&quot;Aminoglycosides&quot;, section on 'Toxicity'</a>.)</p><p class=\"headingAnchor\" id=\"H1261211868\"><span class=\"h2\">Duration of therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NTM SSTI in immune-competent children with isolated cutaneous lesions is usually continued for one to two months after symptom resolution (usually for a minimum of 6 to 12 weeks) [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/46,60\" class=\"abstract_t\">46,60</a>].</p><p class=\"headingAnchor\" id=\"H1060356465\"><span class=\"h2\">Response to therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The response to therapy for NTM SSTI is monitored clinically. We suggest follow-up visits at approximately monthly intervals to ensure that patients are taking and tolerating their medications and that their skin lesions are improving.</p><p>Alternative diagnoses should be considered in patients who have no response to therapy after four to six weeks. At this point, if there is culture-confirmation, it is important to ask about adherence to antimycobacterial therapy and potential for medication malabsorption (eg, vomiting, diarrhea, concurrent administration of other medications that may decrease serum levels of antimycobacterial therapy).</p><p>For patients without definitive microbiologic data who are not improving or are worsening after four to six weeks of antimycobacterial therapy, surgical consultation may be warranted for debridement and to obtain specimens for cultures and histopathology.</p><p>The addition of treatment with antistreptococcal and antistaphylococcal antibiotics also may be warranted to address the possibility of pyogenic superinfection contributing to worsening. When adding agents to an antimycobacterial regimen, it is important to add two drugs (eg, a quinolone and TMP-SMX) to the failing regimen; adding a single drug may predispose to the development of resistance.</p><p class=\"headingAnchor\" id=\"H1510069391\"><span class=\"h1\">PREVENTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Recommendations for the prevention of NTM SSTI in children include [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"abstract_t\">2</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Avoiding the use of benzalkonium chloride as a skin disinfectant because it allows the growth of mycobacteria [<a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/86,87\" class=\"abstract_t\">86,87</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Avoiding alternative medicine practices that involve the injection of unknown or unapproved substances</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In hospitalized patients, avoiding washing or contaminating open wounds with tap water</p><p/><p class=\"headingAnchor\" id=\"H1060357426\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common causes of nontuberculous mycobacterial (NTM) skin and soft tissue infections (SSTI) in children include rapidly growing NTM species (<em>Mycobacterium fortuitum</em>, <em>Mycobacterium abscessus</em>, and <em>Mycobacterium chelonae</em>), <em>Mycobacterium marinum</em>, and<em> Mycobacterium ulcerans</em>. (See <a href=\"#H1060356416\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin abrasions and penetrating trauma are the usual portals of entry for NTM SSTI. The incubation period is variable but usually is between three and four weeks. (See <a href=\"#H1060356423\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>NTM SSTI may occur as an isolated finding in immune-competent children or as part of the clinical spectrum of disseminated disease in immune-compromised patients. NTM SSTI typically follow cutaneous trauma in swimming pools, aquariums, or natural bodies of water. Health care-associated infection may occur at the site of surgery, vascular catheters, or injections. (See <a href=\"#H1060356430\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous NTM infections are polymorphous. Ulcerations (<a href=\"image.htm?imageKey=ID%2F68569\" class=\"graphic graphic_picture graphicRef68569 \">picture 2</a>), plaques, folliculitis, indurated erythematous papules, and nodules (<a href=\"image.htm?imageKey=ID%2F81640\" class=\"graphic graphic_picture graphicRef81640 \">picture 3</a>) have been described. (See <a href=\"#H1060356430\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of NTM SSTI requires isolation of a clinically significant NTM species in culture of biopsy, drainage, or aspirate of fluid from skin nodule, wound, or abscess in a child with compatible clinical findings. Clinical features that should prompt consideration of NTM in a child with SSTI include history of water exposure, penetrating injury, surgical procedure, or injection; negative bacterial cultures (if performed); lack of response to <span class=\"nowrap\">antistaphylococcal/antistreptococcal</span> antibiotics (if administered), and isolation of acid-fast bacilli (AFB) in routine bacterial culture. (See <a href=\"#H1060356444\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of NTM SSTI may require a combination of surgical and medical therapy. Drainage of abscesses and removal of foreign bodies (if present) are essential components of treatment. In addition, surgical debridement is optimal for serious localized disease. (See <a href=\"#H506956714\" class=\"local\">'Surgical therapy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest that children with NTM SSTI be treated with antimycobacterial therapy rather than observation (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Spontaneous resolution may take up to 12 months. (See <a href=\"#H1231497809\" class=\"local\">'Antimycobacterial therapy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pending speciation, we suggest that children with localized, nonulcerated NTM SSTI be treated with a macrolide (<a href=\"topic.htm?path=azithromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">azithromycin</a> or <a href=\"topic.htm?path=clarithromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">clarithromycin</a>) <strong>plus</strong> one of the following: a fluoroquinolone, <a href=\"topic.htm?path=doxycycline-pediatric-drug-information\" class=\"drug drug_pediatric\">doxycycline</a> (for children &ge;8 years), or <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-pediatric-drug-information\" class=\"drug drug_pediatric\">trimethoprim-sulfamethoxazole</a> (<a href=\"image.htm?imageKey=PEDS%2F86161\" class=\"graphic graphic_table graphicRef86161 \">table 2</a>) (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Parenterally administered antimicrobial agent(s) (including <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">amikacin</a>, <a href=\"topic.htm?path=cefoxitin-pediatric-drug-information\" class=\"drug drug_pediatric\">cefoxitin</a>, <a href=\"topic.htm?path=meropenem-pediatric-drug-information\" class=\"drug drug_pediatric\">meropenem</a>) may be warranted for serious disease (eg, ulceration, deep soft tissue infections, device-associated SSTI, and SSTI associated with osteomyelitis), immune-compromised hosts, or if <em>M. <span class=\"nowrap\">abscessus/M</span>. chelonae</em> is suspected. Once the species is identified, we suggest that the child be treated with two drugs to which the isolate is susceptible (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). (See <a href=\"#H1261211780\" class=\"local\">'Empiric therapy'</a> above and <a href=\"#H1261211787\" class=\"local\">'Specific therapy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Therapy is continued for one to two months after symptom resolution (usually for a minimum of 6 to 12 weeks). (See <a href=\"#H1261211868\" class=\"local\">'Duration of therapy'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/1\" class=\"nounderline abstract_t\">Fraser L, Moore P, Kubba H. Atypical mycobacterial infection of the head and neck in children: a 5-year retrospective review. Otolaryngol Head Neck Surg 2008; 138:311.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/2\" class=\"nounderline abstract_t\">Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/3\" class=\"nounderline abstract_t\">Celdr&aacute;n A, Esteban J, Ma&ntilde;as J, Granizo JJ. Wound infections due to Mycobacterium fortuitum after polypropylene mesh inguinal hernia repair. J Hosp Infect 2007; 66:374.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/4\" class=\"nounderline abstract_t\">Ferguson DD, Gershman K, Jensen B, et al. Mycobacterium goodii infections associated with surgical implants at Colorado hospital. Emerg Infect Dis 2004; 10:1868.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/5\" class=\"nounderline abstract_t\">Al Soub H, Al Maslamani M, Al Khuwaiter J, et al. Myocardial abscess and bacteremia complicating Mycobacterium fortuitum pacemaker infection: case report and review of the literature. Pediatr Infect Dis J 2009; 28:1032.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/6\" class=\"nounderline abstract_t\">McNabb A, Eisler D, Adie K, et al. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources. J Clin Microbiol 2004; 42:3000.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/7\" class=\"nounderline abstract_t\">Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003; 16:319.</a></li><li class=\"breakAll\">Mycobacterium. List of prokaryotic names with standing in nomenclature. www.bacterio.cict.fr/m/mycobacterium.html (Accessed on July 21, 2012).</li><li class=\"breakAll\">American Academy of Pediatrics. Diseases caused by nontuberculous mycobacteria. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.831.</li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/10\" class=\"nounderline abstract_t\">Bartralot R, Pujol RM, Garc&iacute;a-Patos V, et al. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol 2000; 27:124.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/11\" class=\"nounderline abstract_t\">Cruz AT, Ong LT, Starke JR. Mycobacterial infections in Texas children: a 5-year case series. Pediatr Infect Dis J 2010; 29:772.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/12\" class=\"nounderline abstract_t\">Chen HY, Chen CY, Huang CT, et al. Skin and soft-tissue infection caused by non-tuberculous mycobacteria in Taiwan, 1997-2008. Epidemiol Infect 2011; 139:121.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/13\" class=\"nounderline abstract_t\">Mahaisavariya P, Chaiprasert A, Khemngern S, et al. Nontuberculous mycobacterial skin infections: clinical and bacteriological studies. J Med Assoc Thai 2003; 86:52.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/14\" class=\"nounderline abstract_t\">Wentworth AB, Drage LA, Wengenack NL, et al. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study. Mayo Clin Proc 2013; 88:38.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/15\" class=\"nounderline abstract_t\">Chesney PJ. Nontuberculous mycobacteria. Pediatr Rev 2002; 23:300.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/16\" class=\"nounderline abstract_t\">Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 1998; 52:453.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/17\" class=\"nounderline abstract_t\">Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995; 20:954.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/18\" class=\"nounderline abstract_t\">Grange JM, Yates MD, Pozniak A. Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in south east England: a recent increase in the number of cases. Arch Dis Child 1995; 72:516.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/19\" class=\"nounderline abstract_t\">Pham-Huy A, Robinson JL, Tapi&eacute;ro B, et al. Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health 2010; 15:276.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/20\" class=\"nounderline abstract_t\">Vu TT, Daniel SJ, Quach C. Nontuberculous mycobacteria in children: a changing pattern. J Otolaryngol 2005; 34 Suppl 1:S40.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/21\" class=\"nounderline abstract_t\">Mangione EJ, Huitt G, Lenaway D, et al. Nontuberculous mycobacterial disease following hot tub exposure. Emerg Infect Dis 2001; 7:1039.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/22\" class=\"nounderline abstract_t\">Fleming GA, Frangoul H, Dermody TS, Halasa N. A cord blood transplant recipient with Mycobacterium mucogenicum central venous catheter infection after infusion of tap water. Pediatr Infect Dis J 2006; 25:567.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/23\" class=\"nounderline abstract_t\">Livni G, Yaniv I, Samra Z, et al. Outbreak of Mycobacterium mucogenicum bacteraemia due to contaminated water supply in a paediatric haematology-oncology department. J Hosp Infect 2008; 70:253.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/24\" class=\"nounderline abstract_t\">Shachor-Meyouhas Y, Sprecher H, Eluk O, et al. An outbreak of Mycobacterium mucogenicum bacteremia in pediatric hematology-oncology patients. Pediatr Infect Dis J 2011; 30:30.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/25\" class=\"nounderline abstract_t\">Falkinham JO 3rd. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis 2011; 17:419.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/26\" class=\"nounderline abstract_t\">Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol 2005; 13:7.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/27\" class=\"nounderline abstract_t\">Escalonilla P, Esteban J, Soriano ML, et al. Cutaneous manifestations of infection by nontuberculous mycobacteria. Clin Exp Dermatol 1998; 23:214.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/28\" class=\"nounderline abstract_t\">Kelly SE. Multiple injection abscesses in a diabetic caused by Mycobacterium chelonei. Clin Exp Dermatol 1987; 12:48.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/29\" class=\"nounderline abstract_t\">Tang P, Walsh S, Murray C, et al. Outbreak of acupuncture-associated cutaneous Mycobacterium abscessus infections. J Cutan Med Surg 2006; 10:166.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/30\" class=\"nounderline abstract_t\">Zhibang Y, BiXia Z, Qishan L, et al. Large-scale outbreak of infection with Mycobacterium chelonae subsp. abscessus after penicillin injection. J Clin Microbiol 2002; 40:2626.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/31\" class=\"nounderline abstract_t\">Castro-Silva AN, Freire AO, Grinbaum RS, et al. Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment. Transpl Infect Dis 2011; 13:33.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/32\" class=\"nounderline abstract_t\">Horii KA, Jackson MA. Images in clinical medicine. Piercing-related nontuberculous mycobacterial infection. N Engl J Med 2010; 362:2012.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/33\" class=\"nounderline abstract_t\">Ferringer T, Pride H, Tyler W. Body piercing complicated by atypical mycobacterial infections. Pediatr Dermatol 2008; 25:219.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/34\" class=\"nounderline abstract_t\">Kennedy BS, Bedard B, Younge M, et al. Outbreak of Mycobacterium chelonae infection associated with tattoo ink. N Engl J Med 2012; 367:1020.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/35\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Tattoo-associated nontuberculous mycobacterial skin infections--multiple states, 2011-2012. MMWR Morb Mortal Wkly Rep 2012; 61:653.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/36\" class=\"nounderline abstract_t\">Schnabel D, Gaines J, Nguyen DB, et al. Notes from the field: rapidly growing nontuberculous Mycobacterium wound infections among medical tourists undergoing cosmetic surgeries in the Dominican Republic--multiple states, March 2013-February 2014. MMWR Morb Mortal Wkly Rep 2014; 63:201.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/37\" class=\"nounderline abstract_t\">Koh SJ, Song T, Kang YA, et al. An outbreak of skin and soft tissue infection caused by Mycobacterium abscessus following acupuncture. Clin Microbiol Infect 2010; 16:895.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/38\" class=\"nounderline abstract_t\">Song JY, Sohn JW, Jeong HW, et al. An outbreak of post-acupuncture cutaneous infection due to Mycobacterium abscessus. BMC Infect Dis 2006; 6:6.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/39\" class=\"nounderline abstract_t\">Dytoc MT, Honish L, Shandro C, et al. Clinical, microbiological, and epidemiological findings of an outbreak of Mycobacterium abscessus hand-and-foot disease. Diagn Microbiol Infect Dis 2005; 53:39.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/40\" class=\"nounderline abstract_t\">Camargo D, Saad C, Ruiz F, et al. Iatrogenic outbreak of M. chelonae skin abscesses. Epidemiol Infect 1996; 117:113.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/41\" class=\"nounderline abstract_t\">Winthrop KL, Abrams M, Yakrus M, et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med 2002; 346:1366.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/42\" class=\"nounderline abstract_t\">Jernigan JA, Farr BM. Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature. Clin Infect Dis 2000; 31:439.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/43\" class=\"nounderline abstract_t\">Parent LJ, Salam MM, Appelbaum PC, Dossett JH. Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency. Clin Infect Dis 1995; 21:1325.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/44\" class=\"nounderline abstract_t\">Friedman BF, Edwards D, Kirkpatrick CH. Mycobacterium avium-intracellulare: cutaneous presentations of disseminated disease. Am J Med 1988; 85:257.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/45\" class=\"nounderline abstract_t\">Hanke CW, Temofeew RK, Slama SL. Mycobacterium kansasii infection with multiple cutaneous lesions. J Am Acad Dermatol 1987; 16:1122.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/46\" class=\"nounderline abstract_t\">Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 2014; 59:147.</a></li><li class=\"breakAll\">Tebruegge M, Curtis N. Mycobacterium nontuberculosis species. In: Principles and Practice of Pediatric Infectious Diseases, 5th ed, Long SS, Prober CG, Fischer M (Eds), Elsevier, Philadelphia 2018. p.806.</li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/48\" class=\"nounderline abstract_t\">Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37:390.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/49\" class=\"nounderline abstract_t\">Casal M, Casal MM, Spanish Group of Mycobacteriology. Multicenter study of incidence of Mycobacterium marinum in humans in Spain. Int J Tuberc Lung Dis 2001; 5:197.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/50\" class=\"nounderline abstract_t\">Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases. J Am Acad Dermatol 2007; 57:413.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/51\" class=\"nounderline abstract_t\">Piersimoni C, Scarparo C. Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerg Infect Dis 2009; 15:1351.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/52\" class=\"nounderline abstract_t\">Edson RS, Terrell CL, Brutinel WM, Wengenack NL. Mycobacterium intermedium granulomatous dermatitis from hot tub exposure. Emerg Infect Dis 2006; 12:821.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/53\" class=\"nounderline abstract_t\">Haimi-Cohen Y, Amir J, Eidlitz-Markus T, et al. Chronic cheek lesions: an unusual manifestation of nontuberculous mycobacterial cevicofacial infection. J Pediatr 2009; 155:746.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/54\" class=\"nounderline abstract_t\">Bartralot R, Garc&iacute;a-Patos V, Sitjas D, et al. Clinical patterns of cutaneous nontuberculous mycobacterial infections. Br J Dermatol 2005; 152:727.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/55\" class=\"nounderline abstract_t\">Peralta G, Tobin-D'Angelo M, Parham A, et al. Notes from the Field: Mycobacterium abscessus Infections Among Patients of a Pediatric Dentistry Practice--Georgia, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:355.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/56\" class=\"nounderline abstract_t\">Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis 1992; 15:1.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/57\" class=\"nounderline abstract_t\">Subbarao EK, Tarpay MM, Marks MI. Soft-tissue infections caused by Mycobacterium fortuitum complex following penetrating injury. Am J Dis Child 1987; 141:1018.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/58\" class=\"nounderline abstract_t\">Kothavade RJ, Dhurat RS, Mishra SN, Kothavade UR. Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 2013; 32:161.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/59\" class=\"nounderline abstract_t\">Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994; 154:1359.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/60\" class=\"nounderline abstract_t\">Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002; 162:1746.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/61\" class=\"nounderline abstract_t\">Uslan DZ, Kowalski TJ, Wengenack NL, et al. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol 2006; 142:1287.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/62\" class=\"nounderline abstract_t\">Van Seymortier P, Verellen K, De Jonge I. Mycobacterium marinum causing tenosynovitis. 'Fish tank finger'. Acta Orthop Belg 2004; 70:279.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/63\" class=\"nounderline abstract_t\">Chan ED, Kong PM, Fennelly K, et al. Vertebral osteomyelitis due to infection with nontuberculous Mycobacterium species after blunt trauma to the back: 3 examples of the principle of locus minoris resistentiae. Clin Infect Dis 2001; 32:1506.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/64\" class=\"nounderline abstract_t\">Song H, Lee H, Choi G, Shin J. Cutaneous nontuberculous mycobacterial infection: a clinicopathological study of 7 cases. Am J Dermatopathol 2009; 31:227.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/65\" class=\"nounderline abstract_t\">Elston D. Nontuberculous mycobacterial skin infections: recognition and management. Am J Clin Dermatol 2009; 10:281.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/66\" class=\"nounderline abstract_t\">Sia TY, Taimur S, Blau DM, et al. Clinical and Pathological Evaluation of Mycobacterium marinum Group Skin Infections Associated With Fish Markets in New York City. Clin Infect Dis 2016; 62:590.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/67\" class=\"nounderline abstract_t\">El Sahly HM, Septimus E, Soini H, et al. Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis 2002; 35:802.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/68\" class=\"nounderline abstract_t\">Subedi S, Kong F, Jelfs P, et al. 16S-23S Internal Transcribed Spacer Region PCR and Sequencer-Based Capillary Gel Electrophoresis has Potential as an Alternative to High Performance Liquid Chromatography for Identification of Slowly Growing Nontuberculous Mycobacteria. PLoS One 2016; 11:e0164138.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/69\" class=\"nounderline abstract_t\">Butler WR, Ahearn DG, Kilburn JO. High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. J Clin Microbiol 1986; 23:182.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/70\" class=\"nounderline abstract_t\">Collina G, Morandi L, Lanzoni A, Reggiani M. Atypical cutaneous mycobacteriosis diagnosed by polymerase chain reaction. Br J Dermatol 2002; 147:781.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/71\" class=\"nounderline abstract_t\">Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985; 28:807.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/72\" class=\"nounderline abstract_t\">Brown BA, Wallace RJ Jr, Onyi GO, et al. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992; 36:180.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/73\" class=\"nounderline abstract_t\">Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1991; 35:773.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/74\" class=\"nounderline abstract_t\">Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985; 152:500.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/75\" class=\"nounderline abstract_t\">Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993; 119:482.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/76\" class=\"nounderline abstract_t\">Khardori N, Nguyen H, Rosenbaum B, et al. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents. Antimicrob Agents Chemother 1994; 38:134.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/77\" class=\"nounderline abstract_t\">Kuhn SM, Rosen W, Wong A, Jadavji T. Treatment of Mycobacterium marinum facial abscess using clarithromycin. Pediatr Infect Dis J 1995; 14:631.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/78\" class=\"nounderline abstract_t\">Esteban J, Fern&aacute;ndez Roblas R, Garc&iacute;a C&iacute;a JI, et al. Clinical significance and epidemiology of non-pigmented rapidly growing mycobacteria in a university hospital. J Infect 2007; 54:135.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/79\" class=\"nounderline abstract_t\">Winthrop KL, Albridge K, South D, et al. The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection. Clin Infect Dis 2004; 38:38.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/80\" class=\"nounderline abstract_t\">Woods GL, Washington JA 2nd. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987; 9:275.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/81\" class=\"nounderline abstract_t\">Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166:405.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/82\" class=\"nounderline abstract_t\">Wallace RJ Jr, Bedsole G, Sumter G, et al. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 1990; 34:65.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/83\" class=\"nounderline abstract_t\">Wallace RJ Jr, Brown-Elliott BA, Ward SC, et al. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001; 45:764.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/84\" class=\"nounderline abstract_t\">Santos A, Cremades R, Rodr&iacute;guez JC, et al. Activity of various drugs alone or in combination against Mycobacterium fortuitum. J Infect Chemother 2010; 16:64.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/85\" class=\"nounderline abstract_t\">Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 2009; 53:1367.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/86\" class=\"nounderline abstract_t\">Tiwari TS, Ray B, Jost KC Jr, et al. Forty years of disinfectant failure: outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin Infect Dis 2003; 36:954.</a></li><li><a href=\"https://www.uptodate.com/contents/nontuberculous-mycobacterial-skin-and-soft-tissue-infections-in-children/abstract/87\" class=\"nounderline abstract_t\">Rikimaru T, Kondo M, Kondo S, Oizumi K. Efficacy of common antiseptics against mycobacteria. Int J Tuberc Lung Dis 2000; 4:570.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 85895 Version 14.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1060357426\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1060356409\" id=\"outline-link-H1060356409\">INTRODUCTION</a></li><li><a href=\"#H1060356416\" id=\"outline-link-H1060356416\">MICROBIOLOGY</a></li><li><a href=\"#H1060356423\" id=\"outline-link-H1060356423\">EPIDEMIOLOGY</a></li><li><a href=\"#H1060356430\" id=\"outline-link-H1060356430\">CLINICAL FEATURES</a><ul><li><a href=\"#H1510067549\" id=\"outline-link-H1510067549\">General features</a></li><li><a href=\"#H1510067648\" id=\"outline-link-H1510067648\">Rapidly growing NTM</a></li><li><a href=\"#H1231497626\" id=\"outline-link-H1231497626\">M. marinum</a></li><li><a href=\"#H1231497680\" id=\"outline-link-H1231497680\">M. ulcerans</a></li><li><a href=\"#H23405905\" id=\"outline-link-H23405905\">M. leprae</a></li><li><a href=\"#H1231497649\" id=\"outline-link-H1231497649\">Immune-compromised host</a></li><li><a href=\"#H1231497657\" id=\"outline-link-H1231497657\">Complications</a></li></ul></li><li><a href=\"#H1060356437\" id=\"outline-link-H1060356437\">HISTOPATHOLOGIC FEATURES</a></li><li><a href=\"#H1060356444\" id=\"outline-link-H1060356444\">DIAGNOSIS</a><ul><li><a href=\"#H1231497480\" id=\"outline-link-H1231497480\">Clinical suspicion</a></li><li><a href=\"#H1231497487\" id=\"outline-link-H1231497487\">Microbiologic testing</a><ul><li><a href=\"#H1510068134\" id=\"outline-link-H1510068134\">- Species identification</a></li></ul></li><li><a href=\"#H1762312486\" id=\"outline-link-H1762312486\">Clinical significance</a></li></ul></li><li><a href=\"#H1060356451\" id=\"outline-link-H1060356451\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H1060356458\" id=\"outline-link-H1060356458\">MANAGEMENT</a><ul><li><a href=\"#H1510068244\" id=\"outline-link-H1510068244\">Overview</a></li><li><a href=\"#H506956714\" id=\"outline-link-H506956714\">Surgical therapy</a></li><li><a href=\"#H1231497809\" id=\"outline-link-H1231497809\">Antimycobacterial therapy</a><ul><li><a href=\"#H1261211780\" id=\"outline-link-H1261211780\">- Empiric therapy</a></li><li><a href=\"#H1261211787\" id=\"outline-link-H1261211787\">- Specific therapy</a></li><li><a href=\"#H2473623173\" id=\"outline-link-H2473623173\">- Adverse effects</a></li></ul></li><li><a href=\"#H1261211868\" id=\"outline-link-H1261211868\">Duration of therapy</a></li><li><a href=\"#H1060356465\" id=\"outline-link-H1060356465\">Response to therapy</a></li></ul></li><li><a href=\"#H1510069391\" id=\"outline-link-H1510069391\">PREVENTION</a></li><li><a href=\"#H1060357426\" id=\"outline-link-H1060357426\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/85895|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/86162\" class=\"graphic graphic_picture\">- Disseminated NTM skin lesions</a></li><li><a href=\"image.htm?imageKey=ID/68569\" class=\"graphic graphic_picture\">- Mycobacterium marinum nodules</a></li><li><a href=\"image.htm?imageKey=ID/81640\" class=\"graphic graphic_picture\">- Fish tank granuloma</a></li><li><a href=\"image.htm?imageKey=ID/50115\" class=\"graphic graphic_picture\">- Lymphocutaneous sporotrichosis arm</a></li><li><a href=\"image.htm?imageKey=ID/74515\" class=\"graphic graphic_picture\">- Fixed cutaneous sporotrichosis</a></li><li><a href=\"image.htm?imageKey=ID/64620\" class=\"graphic graphic_picture\">- New World CL ulceration </a></li><li><a href=\"image.htm?imageKey=DERM/65877\" class=\"graphic graphic_picture\">- Metastatic tuberculous abscesses</a></li><li><a href=\"image.htm?imageKey=DERM/69214\" class=\"graphic graphic_picture\">- Disseminated cryptococcosis - papules</a></li></ul></li><li><div id=\"PEDS/85895|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/61936\" class=\"graphic graphic_table\">- Mycobacteria classification</a></li><li><a href=\"image.htm?imageKey=PEDS/86161\" class=\"graphic graphic_table\">- Treatment NTM children</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=aminoglycosides\" class=\"medical medical_review\">Aminoglycosides</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=azithromycin-clarithromycin-and-telithromycin\" class=\"medical medical_review\">Azithromycin, clarithromycin, and telithromycin</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=buruli-ulcer-mycobacterium-ulcerans-infection\" class=\"medical medical_review\">Buruli ulcer (Mycobacterium ulcerans infection)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-sporotrichosis\" class=\"medical medical_review\">Clinical features and diagnosis of sporotrichosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-nocardiosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of nocardiosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">Cryptococcus neoformans infection outside the central nervous system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cutaneous-leishmaniasis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cutaneous leishmaniasis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cutaneous-manifestations-of-tuberculosis\" class=\"medical medical_review\">Cutaneous manifestations of tuberculosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=disseminated-nontuberculous-mycobacterial-ntm-infections-and-ntm-bacteremia-in-children\" class=\"medical medical_review\">Disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-invasive-aspergillosis\" class=\"medical medical_review\">Epidemiology and clinical manifestations of invasive aspergillosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-of-nontuberculous-mycobacterial-infections\" class=\"medical medical_review\">Epidemiology of nontuberculous mycobacterial infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-osteomyelitis-due-to-nontuberculous-mycobacteria\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of osteomyelitis due to nontuberculous mycobacteria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy\" class=\"medical medical_review\">Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ethambutol-an-overview\" class=\"medical medical_review\">Ethambutol: An overview</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infectious-tenosynovitis\" class=\"medical medical_review\">Infectious tenosynovitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=isoniazid-hepatotoxicity\" class=\"medical medical_review\">Isoniazid hepatotoxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=isoniazid-an-overview\" class=\"medical medical_review\">Isoniazid: An overview</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lymphangitis\" class=\"medical medical_review\">Lymphangitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=manifestations-of-and-risk-factors-for-aminoglycoside-nephrotoxicity\" class=\"medical medical_review\">Manifestations of and risk factors for aminoglycoside nephrotoxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=microbiology-of-nontuberculous-mycobacteria\" class=\"medical medical_review\">Microbiology of nontuberculous mycobacteria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nontuberculous-mycobacterial-lymphadenitis-in-children\" class=\"medical medical_review\">Nontuberculous mycobacterial lymphadenitis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nontuberculous-mycobacterial-pulmonary-infections-in-children\" class=\"medical medical_review\">Nontuberculous mycobacterial pulmonary infections in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-and-clinical-manifestations-of-disseminated-histoplasmosis\" class=\"medical medical_review\">Pathogenesis and clinical manifestations of disseminated histoplasmosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-and-prevention-of-aminoglycoside-nephrotoxicity-and-ototoxicity\" class=\"medical medical_review\">Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-nontuberculous-mycobacterial-infections\" class=\"medical medical_review\">Pathogenesis of nontuberculous mycobacterial infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rapidly-growing-mycobacterial-infections-mycobacteria-abscessus-chelonae-and-fortuitum\" class=\"medical medical_review\">Rapidly growing mycobacterial infections: Mycobacteria abscessus, chelonae, and fortuitum</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rifamycins-rifampin-rifabutin-rifapentine\" class=\"medical medical_review\">Rifamycins (rifampin, rifabutin, rifapentine)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=soft-tissue-infections-following-water-exposure\" class=\"medical medical_review\">Soft tissue infections following water exposure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-leprosy\" class=\"medical medical_review\">Treatment and prevention of leprosy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-osteomyelitis-due-to-nontuberculous-mycobacteria-in-adults\" class=\"medical medical_review\">Treatment of osteomyelitis due to nontuberculous mycobacteria in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tuberculosis-disease-in-children\" class=\"medical medical_review\">Tuberculosis disease in children</a></li></ul></div></div>","javascript":null}